Our research aims to understand molecular mechanisms that contribute to the genomic instability that drives aging and cancer. We place special emphasis on cancers with the poorest prognosis, such is the case of BRCA1 mutated and triple negative breast cancers, and premature aging disorders such as Hutchinson Gilford Progeria Syndrome. Interestingly, we have identified common pathways in both types of disease, and are testing possible therapeutic strategies to ameliorate genomic instability in both contexts.
- 1999: PhD, molecular cell biology, Washington University, St. Louis
- 1999 - 2992: Postdoctoral fellow, molecular oncology, Washington University, St. Louis
- 2002 - 2006: Postdoctoral fellow, molecular oncology, Spanish National Cancer Research Center, Madrid
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.